Try our Advanced Search for more refined results

Leonard Cottrell, et al v. Alcon Laboratories, et al

  1. May 21, 2018

    High Court Won't Look At 3rd Circ. Ruling On Eyedrop Size

    The U.S. Supreme Court on Monday refused to review a Third Circuit ruling that revived a proposed class action accusing Allergan Inc., Pfizer Inc. and other drugmakers of ripping off consumers by selling eyedrops in wasteful dispensers.

  2. November 02, 2017

    Drug Cos. Urge 3rd Circ. To Rethink Eye Drop Suit Ruling

    Pfizer, Merck & Co. and other drug companies told the Third Circuit on Wednesday that its decision last month to revive a putative class action accusing them of boosting eye drop sales by using bottles that dispense larger-than-needed doses requires a rehearing because it went against its own precedent and created a circuit split.

  3. October 12, 2017

    Mass. Ruling Doesn't End NJ Eyedrops Case, 3rd Circ. Told

    A potential class of eyedrops users alleging generic-drug makers such as Sandoz Inc. boosted prescription sales by using bottles that dispensed larger-than-needed drops told the Third Circuit Wednesday that a suit tossed in Massachusetts shouldn't end theirs.

  4. October 06, 2017

    Generic Cos. Say Mass. Ruling Foils 3rd Circ. Eye Drop Case

    Three generic-drug makers including Sandoz Inc. told the Third Circuit on Friday that a recent Massachusetts federal court ruling bolsters their preemption defense to a suit alleging the drugmakers boosted prescription eye drop sales by using bottles that dispensed bigger-than-needed drops.

  5. March 08, 2017

    Drug Cos., Eye Drop Users Spar Over 7th Circ. Toss

    Pfizer, Merck and others urged the Third Circuit on Wednesday to throw out a suit accusing the drugmakers of boosting prescription eye drop sales by using bottles that dispensed bigger-than-needed drops, arguing that the Seventh Circuit recently tossed similar claims.

  6. September 22, 2016

    Drug Cos. Tell 3rd Circ. To Affirm Eye Drop Suit Dismissal

    Pfizer, Merck and others urged the Third Circuit on Wednesday not to revive litigation accusing the drugmakers of boosting prescription eye drop sales by using bottles that dispensed bigger-than-needed drops, contending that a lower court correctly found the patients didn't show sufficient injury.

  7. August 02, 2016

    AARP Urges 3rd Circ. To Revive Eye Drop Suit

    AARP Inc. on Monday urged the Third Circuit to revive a class action accusing drug makers of boosting prescription eye drop sales by using bottles that dispensed higher than necessary doses, arguing that the alleged practice undermines affordable healthcare for older adults.

  8. July 27, 2016

    Cost Of Wasted Eye Drops Counts As Harm, 3rd Circ. Told

    Patients accusing Merck and other drugmakers of boosting prescription eye drop sales by using bottles that dispensed higher than necessary doses have told the Third Circuit their class claims should be revived because the money lost from wasted medicine is a concrete injury.